Preprint Review Version 1 This version is not peer-reviewed

Salidroside as a Modulator of Bone Metabolism: Insight Into the Active Constituent of Rhodiola rosea

Version 1 : Received: 2 July 2024 / Approved: 2 July 2024 / Online: 3 July 2024 (11:46:45 CEST)

How to cite: Wojdasiewicz, P.; Brodacki, S.; Cieślicka, E.; Turczyn, P.; Poniatowski, Ł. A.; Ławniczak, W.; Olczak, M.; Stolarczyk, E. U.; Wróbel, E.; Mikulska, A.; Lach-Gruba, A.; Żuk, B.; Romanowska-Próchnicka, K.; Szukiewicz, D. Salidroside as a Modulator of Bone Metabolism: Insight Into the Active Constituent of Rhodiola rosea. Preprints 2024, 2024070257. https://doi.org/10.20944/preprints202407.0257.v1 Wojdasiewicz, P.; Brodacki, S.; Cieślicka, E.; Turczyn, P.; Poniatowski, Ł. A.; Ławniczak, W.; Olczak, M.; Stolarczyk, E. U.; Wróbel, E.; Mikulska, A.; Lach-Gruba, A.; Żuk, B.; Romanowska-Próchnicka, K.; Szukiewicz, D. Salidroside as a Modulator of Bone Metabolism: Insight Into the Active Constituent of Rhodiola rosea. Preprints 2024, 2024070257. https://doi.org/10.20944/preprints202407.0257.v1

Abstract

Rhodiola rosea, a perennial herb from the Crassulaceae family, contains the bioactive compound salidroside, recognized as an adaptogen with significant therapeutic potential for bone metabolism. Salidroside promotes osteoblast proliferation and differentiation by activating critical signaling pathways, including bone morphogenetic protein-2 and adenosine monophosphate-activated protein kinase, essential for bone formation and growth. It enhances osteogenic activity by increasing alkaline phosphatase activity and mineralization markers, while upregulating key transcription factors such as runt-related transcription factor 2 and osterix. Additionally, salidroside facilitates angiogenesis via the hypoxia-inducible factor 1-alpha and vascular endothelial growth factor pathway, crucial for coupling bone formation with vascular support. Its antioxidant properties offer protection against bone loss by reducing oxidative stress and promoting osteogenic differentiation through the nuclear factor erythroid 2–related factor 2 pathway. Salidroside's ability to counteract the negative effects of glucocorticoids on bone cells and prevent steroid-induced osteonecrosis, along with its anti-inflammatory properties, enhances its potential in treating conditions like osteoarthritis. These attributes underscore its multifaceted role in bone metabolism. This article reviews the literature, including in vitro and in vivo studies primarily on rodent models, demonstrating salidroside's efficacy in mitigating bone loss, preserving bone microarchitecture, and accelerating fracture healing. Future research directions to explore salidroside’s applications in bone-related diseases are also highlighted.

Keywords

salidroside; adaptogens; bone metabolism; osteoporosis; Rhodiola rosea; bone loss; fracture healing; osteoblasts

Subject

Medicine and Pharmacology, Dietetics and Nutrition

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.